The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

Näytä muut versiot (1)

Lineage fate decisions underpin much of development as well as tissue homeostasis in the adult. A mechanistic paradigm for such decisions is the erythroid versus myeloid fate decision controlled by cross-antagonism between gata1 and pu.1 transcription factors. In this study, we have systematically t...

Bibliografiset tiedot
Päätekijät:	Monteiro, R, Pouget, C, Patient, R
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2011

Samankaltaisia teoksia

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ
Tekijä: Monteiro, R, et al.
Julkaistu: (2011)

Lineage marker synchrony in hematopoietic genealogies refutes the PU.1/GATA1 toggle switch paradigm
Tekijä: Michael K. Strasser, et al.
Julkaistu: (2018-07-01)

The Roles of TIF1γ in Cancer
Tekijä: Chengpeng Yu, et al.
Julkaistu: (2019-10-01)

Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios
Tekijä: Hoppe, P, et al.
Julkaistu: (2016)

Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
Tekijä: Yorihisa Kotobuki, et al.
Julkaistu: (2021-01-01)

GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
Tekijä: Nerlov, C, et al.
Julkaistu: (2000)

Clinical characteristics of patients with anti-TIF1-γ antibodies
Tekijä: Anna Masiak, et al.
Julkaistu: (2016-03-01)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
Tekijä: Daniel Gutierrez, MD, et al.
Julkaistu: (2022-04-01)

Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1.
Tekijä: Liew, C, et al.
Julkaistu: (2006)

PU.1 and Haematopoietic Cell Fate: Dosage Matters
Tekijä: Ka Sin Mak, et al.
Julkaistu: (2011-01-01)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
Tekijä: Spyridon Megremis, et al.
Julkaistu: (2021-03-01)

Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesis
Tekijä: Rossmann, Marlies P, et al.
Julkaistu: (2021)

GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.
Tekijä: Elsa P Amanatiadou, et al.
Julkaistu: (2015-01-01)

Inferring structural properties of protein-DNA binding using high-throughput sequencing. The paradigm of GATA1, KLF1 and their complexes GATA1/FOG1 and GATA1/KLF1. Insights into the transcriptional regulation of the erythroid cell lineage.
Tekijä: Oikonomopoulos, S
Julkaistu: (2014)

Amyopathic anti‐TIF1‐γ antibody‐positive dermatomyositis in a young man
Tekijä: Nicolas Kluger
Julkaistu: (2024-07-01)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
Tekijä: Upasana Agrawal MD, et al.
Julkaistu: (2024-06-01)

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
Tekijä: B. Palterer, et al.
Julkaistu: (2017-08-01)

Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.
Tekijä: Geoffroy Andrieux, et al.
Julkaistu: (2012-01-01)

Correction: Inactivation of TIF1γ Cooperates with Kras to Induce Cystic Tumors of the Pancreas.
Tekijä: David F. Vincent, et al.
Julkaistu: (2009-08-01)

Anti‐TIF‐1γ dermatomyositis: Erythematous eruption with weakness and normal creatine kinase
Tekijä: Lucy Mackie, et al.
Julkaistu: (2024-06-01)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
Tekijä: Chih-Feng Wu, et al.
Julkaistu: (2023-09-01)

Association of Mutation and Methylation in the Promoter Region of TIF1γ  with Non-small Cell Lung Cancer
Tekijä: Longqiang WANG, et al.
Julkaistu: (2013-05-01)

Correction: Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
Julkaistu: (2009-08-01)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
Tekijä: Natsuo Tomita, MD, PhD, et al.
Julkaistu: (2021-07-01)

Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
Tekijä: Bakri, Y, et al.
Julkaistu: (2005)

PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
Tekijä: Takuya Yashiro, et al.
Julkaistu: (2015-01-01)

Lineage-specific combinatorial action of enhancers regulates mouse erythroid Gata1 expression.
Tekijä: Drissen, R, et al.
Julkaistu: (2010)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
Tekijä: Ryosuke Imai, et al.
Julkaistu: (2021-04-01)

PTEN regulates hematopoietic lineage plasticity via PU.1-dependent chromatin accessibility
Tekijä: Zihan Xu, et al.
Julkaistu: (2023-08-01)

Association Between Anti‐TIF1‐γ Antibody and Triple‐Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report
Tekijä: Fan Zhang, et al.
Julkaistu: (2025-02-01)

A Case of Paraneoplastic Anti-TIF1-γ Antibody-Positive Dermatomyositis Presenting with Generalized Edema and Associated with Aortic Aneurysm
Tekijä: Raven Bennett, et al.
Julkaistu: (2023-10-01)

Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice
Tekijä: Anaís Mariscal, et al.
Julkaistu: (2021-02-01)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
Tekijä: Joanna E. Parkes, et al.
Julkaistu: (2018-06-01)

The TIF1β-HP1 System Maintains Transcriptional Integrity of Hematopoietic Stem Cells
Tekijä: Satoru Miyagi, et al.
Julkaistu: (2014-02-01)

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
Tekijä: Xinhui Zhao, et al.
Julkaistu: (2022-09-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
Tekijä: Jason Kieffer, MD, et al.
Julkaistu: (2024-03-01)

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Tekijä: Gering, M, et al.
Julkaistu: (2003)

Case Report: IVIG causing bilateral papilledema and increased intracranial hypertension in patients with anti-TIF-1γ antibody-positive JDM
Tekijä: Sarah Baluta, et al.
Julkaistu: (2024-11-01)

A Case Report of Anti-TIF1-γAntibody-Positive Dermatomyositis Concomitant with Small Cell Neuroendocrine Carcinoma of the Urinary Bladder
Tekijä: Hiroyuki Hounoki, et al.
Julkaistu: (2023-01-01)

Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
Tekijä: Lijuan Zhao, et al.
Julkaistu: (2022-02-01)